Riskpilot← Back to searchSign inGet full accessÖgonhälsan BA AB
ABActiveOrg 5567577746Södra Vägen 2Medical specialists activities · NACE 8622Est. 20082 employees
Revenue 2025
SEK 1,4M
-35% vs 2024
EBITDA margin
-9.7%
-116% vs 2024
Equity ratio
79.9%
Financial strength
Net profit 2025
SEK 361K
-70% vs 2024
| Revenue | SEK 1,4M | -35% |
| EBITDA | SEK -137K | -116% |
| Net profit | SEK 361K | -70% |
| Total assets | SEK 13,6M | -3% |
| Equity | SEK 10,9M | +0% |
| Employees | 2 | — |
Legal name
Ögonhälsan BA AB
Org number
5567577746
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
12 maj 2008
Share capital
SEK 120 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva medicinsk konsultation, utbildning, dokumentation, läkarpraktik, äga och förvalta fast egendom, aktier och andra värdehandlingar samt därmed förenlig verksamhet.
Address
Södra Vägen 2
Phone
+46705409540
Email
ogonexperterna@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 112 | 2 684 | 2 692 | 2 169 | 1 415 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 879 | 1 432 | 1 369 | 844 | −137 |
| Depreciation & amort. | −110 | −129 | −123 | −83 | −83 |
| EBIT | 1 769 | 1 303 | 1 246 | 761 | −220 |
| Net financials | 18 | 19 | −736 | 609 | 233 |
| Profit before tax | 1 787 | 1 241 | 900 | 1 499 | 481 |
| Tax | −391 | −268 | −284 | −302 | −120 |
| Net profit | 1 396 | 973 | 616 | 1 197 | 361 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 13 449 | 14 170 | 13 225 | 13 958 | 13 605 |
| Equity | 10 084 | 10 747 | 9 981 | 10 843 | 10 869 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 470 | 446 | 271 | 271 | 346 |
| Total debt | 470 | 446 | 271 | 271 | 346 |
EBITDA margin
-9.7%
This company
15.8%
Market median
-161% vs market
20212025
Equity ratio
79.9%
This company
38.2%
Market median
+109% vs market
20212025
Return on equity
3.3%
This company
18.4%
Market median
-82% vs market
20212025
Net profit margin
25.5%
This company
8.1%
Market median
+215% vs market
20212025
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20212025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
KG Audit | Audit | 2022 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ögonhälsan BA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Göran Carlsson | Audit | 0 companies |
| Jan Gustav Andersén | Deputy Board Member | 0 companies |
| Bo Tryggve Andersén | Board of Directors | 0 companies |